International Law Office
Trade Negotiators Seek Comment on Elimination of Pharmaceutical Import Duties
April 23, 2010
Over 9,000 pharmaceutical and chemical intermediates enjoy duty free treatment under the customs regime of the United States and other countries that participate in the World Trade Organization Pharmaceutical Agreement. The Office of the U.S. Trade Representative is seeking public comment on the possible expansion of the list of products subject to this reciprocal duty free treatment (comments were due by April 9, 2010).
This Sidley Update was republished by ILO in its Trade & Customs Newsletter.
得意分野
Suggested News & Insights
Sidley Recognized in Legal 500 Greater China 2027November 19, 2026New Export Controls on Advanced Chips Close Remote Compute Access "Loopholes": Five Key TakeawaysNovember 19, 2026Sidley Represents Five9 in Its US$325 Million Acquisition of Level AINovember 5, 2026Sidley Represents Laza Medical in Its US$160 Million Series B Financing RoundNovember 4, 2026White House Pursues Trade Talks on Robotics and Machinery, Holds Off on TariffsNovember 3, 2026Six Sidley Partners Honored as 2026 “MVPs” by Law360November 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory